BackGenelink Overview

Genelink Long Term Debt

Track Genelink's long-term debt ($1.2M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$1.19M
↑ 12.62% YoYΔ $133394.00 vs prior year quarter

Peer trimmed avg / median

Loading

Genelink Long Term Debt History

Loading

Genelink vs. peers: Long Term Debt Comparison

Loading

Genelink Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Genelink (GNLKQ) FAQ

As of the most recent data (September 2013), GNLKQ shows a long-term debt of $1.2M. That compares with $1.1M in the prior-year period — up 12.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GNLKQ's long-term debt is now $1.2M (was $1.1M) — a 12.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Genelink is outperforming or lagging.

Tracking GNLKQ's long-term debt over time shows whether Genelink is scaling, shrinking, or reshaping that part of the business. The current reading is $1.2M That compares with $1.1M in the prior-year period — up 12.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Genelink's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $1.2M) with ownership activity and broader fundamentals.

Genelink's long-term debt is $1.2M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.